Danaher Corporation

DHR Healthcare Diagnostics & Research

Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024. In the quarter to June 2026, revenue grew 5.54%, EPS grew 59.7%, free cash flow grew 15.6% and total debt rose 49.2%, each against the same quarter a year earlier. Member of the S&P 500.

228.97 2.53 −1.09%
Market cap
$162.7B
P/E
40.5×
Fwd P/E
29.2×
Dividend yield
0.66%
F-score
6/9
Altman Z
4.52
Beneish M
−2.57
Dividend safety
69/100

Danaher Corporation (DHR) Operating cash flow

Alert me on Operating cash flow

Danaher Corporation's operating cash flow for fiscal 2025 was $6.4B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $6.6B. Over the past ten years it has ranged from $3.5B (fiscal 2017) to $8.5B (fiscal 2022); the current reading is higher than 64% of that period. Operating cash flow has fallen for 3 consecutive fiscal years. Danaher Corporation ranks 2nd of 52 Diagnostics & Research companies by operating cash flow.

Operating cash flow, annual

Embed this chart

Annual newest first

Period Operating cash flow Change
FY2025 $6.4B (4.07%)
FY2024 $6.7B (6.64%)
FY2023 $7.2B (15.91%)
FY2022 $8.5B 1.93%
FY2021 $8.4B 34.63%
FY2020 $6.2B 57.09%
FY2019 $4.0B (1.74%)
FY2018 $4.0B 15.65%
FY2017 $3.5B (1.25%)
FY2016 $3.5B (7.36%)

Quarterly newest first

Period Operating cash flow Change
Jun 2026 $1.5B 16.04%
Mar 2026 $1.3B (37.55%)
Dec 2025 $2.1B 27.38%
Sep 2025 $1.7B 24.22%
42 more quarters

Against its own ten years

Low $3.5B High $8.5B
Ten-year median $6.2B
Current reading's percentile 64

Operating cash flow against peers

What Operating cash flow is

Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.

Reported line item

The full definition of Operating cash flow →

More on DHR